中华医学会糖尿病学分会|南方医科大学沈洁教授:院内血糖管理模式探索及创新

2022-09-17 MedSci原创 MedSci原创

来自南方医科大学顺德医院的沈洁教授针对“院内血糖管理模式探索及创新”进行了专题报告。

由中华医学会、中华医学会糖尿病学分会主办,上海交通大学附属第六人民医院协办的“中华医学会糖尿病学分会2022年糖尿病监测与治疗新技术学术会议”于2022年9月16-17日在线上精彩呈现。

在2022年9月17日的中华医学会糖尿病学分会中,来自南方医科大学顺德医院的沈洁教授针对“院内血糖管理模式探索及创新”进行了专题报告。

 

“双向会诊功能”和“虚拟病区”为精细化管理而生,实现以专业科室为主导的全院血糖监测提高血糖达标率,缓解现有医患比例不足的矛盾,提高患者满意度。而为了达到上述标准,沈教授

随后,沈教授介绍了大数据挖掘对智能化血糖监测的促进作用。首先,CGMS进入全院信息化血糖管理系统,实现院内多科室远程实时血糖监测,减少医护工作符合,实现搞笑患者管理。

同时,沈教授介绍了该院配备的现金预警系统,其中GUARDIAN CONNECT系统能够最大提前60分钟对高/低血糖的发生采取预警,方便采取预防措施。为此,该系统减少了60%的低血糖事件。

沈教授指出,挖掘数据价值,血糖管理数据可视化,也提高了工作效率,增进管理的效果;多维度了解全院血糖管理情况,便于制定本院的管理办法;寻找血糖管理共同规律,为静候DRG/DIP入组做好数据支撑和理论依据。

而在预防低血糖发生方面,通过对具体科室的数据进行分析,能具体探寻疾病谱、血糖管理、用药和低血糖的预防。因此,提高了全院危急情况处置水平,减少危急情况发生。

沈教授提出,挖掘血糖大数据,反过来提高了医院的精准化管理和效益,为迎接DRG/DIP支付方式改革做好准备。

随后,沈教授以该院为例子,提出院际“顺德模式”的探索之路,这是由政府主导的简历顺德区糖尿病医防协同联盟共同推动。目前已建立该院与全区十个镇街道医院的院际院内血糖管理信息平台。

在此基础下,也成立了区域糖尿病质控中心,共建了分级标准对医院进行考核。从社区卫生服务中心到三级医院,共同探讨更好的患者管理模式。

最后,沈教授对授课内容进行总结:

1.院内血糖管理情况不容乐观;

2.后疫情时代是分级诊疗落地的实际,医改当下慢病下沉基层是必然趋势,承担起更多的院内、院外血糖管理职责是未来内分泌专科的生存法则;

3.院内血糖管理应规范临床路径,应用信息化管理手段,完成糖尿病院内-院外全病程闭环管理;

4.利用信息化手段,创新性挖掘数据价值,提高医院管理效益和价值,助力智慧管理水平提升。

 

 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1923184, encodeId=97bc192318435, content=<a href='/topic/show?id=97f835221ba' target=_blank style='color:#2F92EE;'>#医科大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35221, encryptionId=97f835221ba, topicName=医科大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fa8I6JticHgohY5FSGE98I1F4gpCjrpl2nbN6jZJY6JEqAjUibjItOA9AsgbBwTuBzAPbU5Tl8DxfemWUFFzBOYw/132, createdBy=24c12500054, createdName=ms2186806800017884, createdTime=Sun Jun 18 03:28:25 CST 2023, time=2023-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286132, encodeId=fa1912861328b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521579, encodeId=32c915215e982, content=<a href='/topic/show?id=3c4e8985327' target=_blank style='color:#2F92EE;'>#血糖管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89853, encryptionId=3c4e8985327, topicName=血糖管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2da11366066, createdName=zhangying8792, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625336, encodeId=ff22162533603, content=<a href='/topic/show?id=604fe6046b2' target=_blank style='color:#2F92EE;'>#管理模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76046, encryptionId=604fe6046b2, topicName=管理模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8adf20737369, createdName=zhangj7115, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1923184, encodeId=97bc192318435, content=<a href='/topic/show?id=97f835221ba' target=_blank style='color:#2F92EE;'>#医科大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35221, encryptionId=97f835221ba, topicName=医科大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fa8I6JticHgohY5FSGE98I1F4gpCjrpl2nbN6jZJY6JEqAjUibjItOA9AsgbBwTuBzAPbU5Tl8DxfemWUFFzBOYw/132, createdBy=24c12500054, createdName=ms2186806800017884, createdTime=Sun Jun 18 03:28:25 CST 2023, time=2023-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286132, encodeId=fa1912861328b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521579, encodeId=32c915215e982, content=<a href='/topic/show?id=3c4e8985327' target=_blank style='color:#2F92EE;'>#血糖管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89853, encryptionId=3c4e8985327, topicName=血糖管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2da11366066, createdName=zhangying8792, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625336, encodeId=ff22162533603, content=<a href='/topic/show?id=604fe6046b2' target=_blank style='color:#2F92EE;'>#管理模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76046, encryptionId=604fe6046b2, topicName=管理模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8adf20737369, createdName=zhangj7115, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1923184, encodeId=97bc192318435, content=<a href='/topic/show?id=97f835221ba' target=_blank style='color:#2F92EE;'>#医科大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35221, encryptionId=97f835221ba, topicName=医科大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fa8I6JticHgohY5FSGE98I1F4gpCjrpl2nbN6jZJY6JEqAjUibjItOA9AsgbBwTuBzAPbU5Tl8DxfemWUFFzBOYw/132, createdBy=24c12500054, createdName=ms2186806800017884, createdTime=Sun Jun 18 03:28:25 CST 2023, time=2023-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286132, encodeId=fa1912861328b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521579, encodeId=32c915215e982, content=<a href='/topic/show?id=3c4e8985327' target=_blank style='color:#2F92EE;'>#血糖管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89853, encryptionId=3c4e8985327, topicName=血糖管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2da11366066, createdName=zhangying8792, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625336, encodeId=ff22162533603, content=<a href='/topic/show?id=604fe6046b2' target=_blank style='color:#2F92EE;'>#管理模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76046, encryptionId=604fe6046b2, topicName=管理模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8adf20737369, createdName=zhangj7115, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1923184, encodeId=97bc192318435, content=<a href='/topic/show?id=97f835221ba' target=_blank style='color:#2F92EE;'>#医科大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35221, encryptionId=97f835221ba, topicName=医科大学)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fa8I6JticHgohY5FSGE98I1F4gpCjrpl2nbN6jZJY6JEqAjUibjItOA9AsgbBwTuBzAPbU5Tl8DxfemWUFFzBOYw/132, createdBy=24c12500054, createdName=ms2186806800017884, createdTime=Sun Jun 18 03:28:25 CST 2023, time=2023-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286132, encodeId=fa1912861328b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521579, encodeId=32c915215e982, content=<a href='/topic/show?id=3c4e8985327' target=_blank style='color:#2F92EE;'>#血糖管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89853, encryptionId=3c4e8985327, topicName=血糖管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2da11366066, createdName=zhangying8792, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625336, encodeId=ff22162533603, content=<a href='/topic/show?id=604fe6046b2' target=_blank style='color:#2F92EE;'>#管理模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76046, encryptionId=604fe6046b2, topicName=管理模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8adf20737369, createdName=zhangj7115, createdTime=Mon Sep 19 04:28:25 CST 2022, time=2022-09-19, status=1, ipAttribution=)]